vs
Side-by-side financial comparison of AMN HEALTHCARE SERVICES INC (AMN) and Hologic (HOLX). Click either name above to swap in a different company.
Hologic is the larger business by last-quarter revenue ($1.0B vs $748.2M, roughly 1.4× AMN HEALTHCARE SERVICES INC). Hologic runs the higher net margin — 17.1% vs -1.0%, a 18.1% gap on every dollar of revenue. On growth, Hologic posted the faster year-over-year revenue change (2.5% vs 1.8%). Hologic produced more free cash flow last quarter ($215.2M vs $67.6M). Over the past eight quarters, Hologic's revenue compounded faster (1.5% CAGR vs -4.5%).
AMN Healthcare Services Inc. is a leading US healthcare sector workforce solutions and staffing provider. It offers temporary and permanent placement for nurses, physicians, allied health and other clinical/non-clinical staff, plus workforce management tools and consulting for hospitals, clinics and other medical facilities.
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
AMN vs HOLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $748.2M | $1.0B |
| Net Profit | $-7.7M | $179.1M |
| Gross Margin | 26.1% | 56.0% |
| Operating Margin | 1.1% | 22.6% |
| Net Margin | -1.0% | 17.1% |
| Revenue YoY | 1.8% | 2.5% |
| Net Profit YoY | 95.9% | -10.9% |
| EPS (diluted) | $-0.19 | $0.79 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $748.2M | $1.0B | ||
| Q3 25 | $634.5M | $1.0B | ||
| Q2 25 | $658.2M | $1.0B | ||
| Q1 25 | $689.5M | $1.0B | ||
| Q4 24 | $734.7M | $1.0B | ||
| Q3 24 | $687.5M | $988.0M | ||
| Q2 24 | $740.7M | $1.0B | ||
| Q1 24 | $820.9M | $1.0B |
| Q4 25 | $-7.7M | $179.1M | ||
| Q3 25 | $29.3M | $187.2M | ||
| Q2 25 | $-116.2M | $194.9M | ||
| Q1 25 | $-1.1M | $-17.4M | ||
| Q4 24 | $-187.5M | $201.0M | ||
| Q3 24 | $7.0M | $178.6M | ||
| Q2 24 | $16.2M | $194.5M | ||
| Q1 24 | $17.3M | $169.9M |
| Q4 25 | 26.1% | 56.0% | ||
| Q3 25 | 29.1% | 55.6% | ||
| Q2 25 | 29.8% | 56.3% | ||
| Q1 25 | 28.7% | 37.5% | ||
| Q4 24 | 29.8% | 56.8% | ||
| Q3 24 | 31.0% | 56.4% | ||
| Q2 24 | 31.0% | 55.4% | ||
| Q1 24 | 31.4% | 53.3% |
| Q4 25 | 1.1% | 22.6% | ||
| Q3 25 | 7.5% | 22.6% | ||
| Q2 25 | -18.8% | 24.9% | ||
| Q1 25 | 1.8% | -0.7% | ||
| Q4 24 | -27.6% | 22.5% | ||
| Q3 24 | 3.2% | 23.3% | ||
| Q2 24 | 5.1% | 24.1% | ||
| Q1 24 | 4.9% | 20.7% |
| Q4 25 | -1.0% | 17.1% | ||
| Q3 25 | 4.6% | 17.8% | ||
| Q2 25 | -17.7% | 19.0% | ||
| Q1 25 | -0.2% | -1.7% | ||
| Q4 24 | -25.5% | 19.7% | ||
| Q3 24 | 1.0% | 18.1% | ||
| Q2 24 | 2.2% | 19.2% | ||
| Q1 24 | 2.1% | 16.7% |
| Q4 25 | $-0.19 | $0.79 | ||
| Q3 25 | $0.76 | $0.84 | ||
| Q2 25 | $-3.02 | $0.86 | ||
| Q1 25 | $-0.03 | $-0.08 | ||
| Q4 24 | $-4.90 | $0.87 | ||
| Q3 24 | $0.18 | $0.75 | ||
| Q2 24 | $0.42 | $0.82 | ||
| Q1 24 | $0.45 | $0.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $2.4B |
| Total DebtLower is stronger | $767.1M | $2.5B |
| Stockholders' EquityBook value | $642.1M | $5.2B |
| Total Assets | $2.1B | $9.2B |
| Debt / EquityLower = less leverage | 1.19× | 0.48× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | $2.4B | ||
| Q3 25 | $52.6M | $2.2B | ||
| Q2 25 | $41.5M | $1.9B | ||
| Q1 25 | $55.8M | $1.6B | ||
| Q4 24 | $10.6M | $2.0B | ||
| Q3 24 | $30.6M | $2.3B | ||
| Q2 24 | $48.0M | $2.4B | ||
| Q1 24 | $50.6M | $2.2B |
| Q4 25 | $767.1M | $2.5B | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | $1.1B | $2.5B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | $642.1M | $5.2B | ||
| Q3 25 | $644.4M | $5.0B | ||
| Q2 25 | $607.6M | $4.8B | ||
| Q1 25 | $715.1M | $4.6B | ||
| Q4 24 | $706.6M | $4.8B | ||
| Q3 24 | $890.7M | $5.1B | ||
| Q2 24 | $876.9M | $5.0B | ||
| Q1 24 | $854.2M | $4.8B |
| Q4 25 | $2.1B | $9.2B | ||
| Q3 25 | $2.1B | $9.0B | ||
| Q2 25 | $2.2B | $8.8B | ||
| Q1 25 | $2.4B | $8.5B | ||
| Q4 24 | $2.4B | $8.7B | ||
| Q3 24 | $2.7B | $9.2B | ||
| Q2 24 | $2.8B | $8.9B | ||
| Q1 24 | $2.9B | $8.7B |
| Q4 25 | 1.19× | 0.48× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | 1.49× | 0.53× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 0.51× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.6M | $229.9M |
| Free Cash FlowOCF − Capex | $67.6M | $215.2M |
| FCF MarginFCF / Revenue | 9.0% | 20.5% |
| Capex IntensityCapex / Revenue | 1.1% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 1.28× |
| TTM Free Cash FlowTrailing 4 quarters | $233.8M | $1.0B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.6M | $229.9M | ||
| Q3 25 | $22.7M | $355.1M | ||
| Q2 25 | $78.5M | $343.3M | ||
| Q1 25 | $92.7M | $169.4M | ||
| Q4 24 | $72.8M | $189.3M | ||
| Q3 24 | $66.7M | $367.0M | ||
| Q2 24 | $99.5M | $405.8M | ||
| Q1 24 | $81.4M | $292.4M |
| Q4 25 | $67.6M | $215.2M | ||
| Q3 25 | $14.8M | $341.4M | ||
| Q2 25 | $68.7M | $330.5M | ||
| Q1 25 | $82.7M | $153.9M | ||
| Q4 24 | $56.6M | $172.5M | ||
| Q3 24 | $47.4M | $350.6M | ||
| Q2 24 | $72.2M | $385.3M | ||
| Q1 24 | $63.2M | $279.6M |
| Q4 25 | 9.0% | 20.5% | ||
| Q3 25 | 2.3% | 32.5% | ||
| Q2 25 | 10.4% | 32.3% | ||
| Q1 25 | 12.0% | 15.3% | ||
| Q4 24 | 7.7% | 16.9% | ||
| Q3 24 | 6.9% | 35.5% | ||
| Q2 24 | 9.8% | 38.1% | ||
| Q1 24 | 7.7% | 27.5% |
| Q4 25 | 1.1% | 1.4% | ||
| Q3 25 | 1.2% | 1.3% | ||
| Q2 25 | 1.5% | 1.3% | ||
| Q1 25 | 1.4% | 1.5% | ||
| Q4 24 | 2.2% | 1.6% | ||
| Q3 24 | 2.8% | 1.7% | ||
| Q2 24 | 3.7% | 2.0% | ||
| Q1 24 | 2.2% | 1.3% |
| Q4 25 | — | 1.28× | ||
| Q3 25 | 0.77× | 1.90× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | 9.54× | 2.05× | ||
| Q2 24 | 6.13× | 2.09× | ||
| Q1 24 | 4.70× | 1.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
